Page 98 - JCTR-11-2
P. 98

Journal of Clinical and
            Translational Research                                        Biomimetic matrix used to treat diabetic foot ulcers



            which  require  thawing  and/or  additional  manipulation   Funding
            such as cutting to size, rehydrating, or reconstituting, the
            BMM delivery system is ready to use and easy to apply.  None.
              Historically,  other  biomaterials  used  in  wound   Conflict of interest
            management do not address some of the most critical factors   The authors declare no conflict of interest.
            to achieving wound closure. Collagen-based materials, for
            instance, provide a substrate for cellular migration and   Author contributions
            proliferation and may help reduce enzymatic degradation
            but do not control bioburden and are, in fact, prone to   Conceptualization: Adam Landsman
            microbial colonization.  Living cell materials have been   Investigation: All authors
                               13
            shown to stimulate wound healing by introducing growth   Methodology: Adam Landsman
            factors in addition to an ECM, but they also fail to reduce   Writing – original draft: All authors
            bioburden during the healing process and are constrained   Writing – review & editing: All authors
            by other limitations including low cell survival post-  Ethics approval and consent to participant
            delivery or even adverse events such as immunogenicity.
                                                               This  work  has  been  approved  by  Massachusetts  General
              BMM mimics the native ECM, which is critical in   Brigham IRB, Protocol #2025P000269.
            supporting cellular infiltration and revascularization
            while  also  functioning  as  an  antibacterial  barrier  to   Consent for publication
            contamination. The specifically designed delivery system
            enables precise application and intimate contact of the   Not applicable.
            BMM with the wound bed, including hard-to-reach areas,   Availability of data
            and therefore eliminates dead space. The self-stable, sterile,
            ready, and easy-to-use system makes it a convenient   Data is available from the corresponding author upon
            product across different wound care settings. The fact that   reasonable request.
            the matrix is resorbable and fully integrated with the tissue
            is also beneficial, as it does not require product removal at   References
            dressing changes, which could disrupt the newly developed   1.   Darwin E, Tomic-Canic M. Healing chronic wounds:
            tissue and delay the healing process. BMM was uniquely   Current challenges and potential solutions. Curr Dermatol
            designed to address the specific clinical needs of a chronic   Rep. 2018;7(4):296-302.
            wound and to address the shortcomings of other treatment      doi: 10.1007/s13671-018-0239-4
            options.
                                                               2.   Vecin NM, Kirsner RS. Skin substitutes as treatment for
            5. Conclusion                                         chronic wounds: Current and future directions. Front Med
                                                                  (Lausanne). 2023;10:1154567.
            In this small case series, we explored the use of BMM, a
            novel class of self-assembling peptide-based biomaterial      doi: 10.3389/fmed.2023.1154567
            for wound care. The findings demonstrate  that BMM   3.   Singh AV, Chandrasekar V, Prabhu VM, et al. Sustainable
            treatment rapidly reduced wound area, improved overall   bioinspired  materials  for  regenerative  medicine:
            appearance, and reduced the depth of complex diabetic   Balancing toxicology, environmental impact, and ethical
            lower extremity wounds. Considering the limitations of a   considerations. Biomed Mater. 2024;19(6):1-17.
            case series, it is important to note that this study lacks the      doi: 10.1088/1748-605X/ad85bb
            statistical rigor and appropriate methodology to support   4.   Haines LA, Rajagopal K, Ozbas B, Salick DA, Pochan DJ,
            BMM’s efficacy. However, these results provide insights   Schneider JP. Light-activated hydrogel formation via the
            into the potential use of this innovative product to treat   triggered folding and self-assembly of a designed peptide.
            and  manage  complex  chronic  wounds. Further  studies,   J Am Chem Soc. 2005;127:17025-17029.
            preferably randomized clinical trials, are needed to validate      doi: 10.1021/ja054719o
            and expand the findings from this study.
                                                               5.   Jafari A. Advancements in self-assembling peptides:
            Acknowledgments                                       Bridging gaps in 3D cell culture and electronic device
                                                                  fabrication. J Biomater Appl. 2024;38(10):1013-1035.
            The authors would like to thank Ana Tellechea, Brunno
            Caetano, Manav Mehta, Daljit Kaur, and Rebecca Salamone      doi: 10.1177/08853282241240139
            for their help and guidance with this study.       6.   La Manna S, Di Natale C, Onesto V, Marasco D. Self-


            Volume 11 Issue 2 (2025)                        92                            doi: 10.36922/jctr.24.00063
   93   94   95   96   97   98   99   100   101   102   103